FR2760746A1 - New acyl:amino acid derivatives used in cosmetics, hygiene compositions, agriculture and therapeutic compositions - Google Patents
New acyl:amino acid derivatives used in cosmetics, hygiene compositions, agriculture and therapeutic compositions Download PDFInfo
- Publication number
- FR2760746A1 FR2760746A1 FR9703135A FR9703135A FR2760746A1 FR 2760746 A1 FR2760746 A1 FR 2760746A1 FR 9703135 A FR9703135 A FR 9703135A FR 9703135 A FR9703135 A FR 9703135A FR 2760746 A1 FR2760746 A1 FR 2760746A1
- Authority
- FR
- France
- Prior art keywords
- compositions
- acylating agent
- acylamino acids
- acids according
- salified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims abstract description 8
- 125000002252 acyl group Chemical group 0.000 title description 5
- 230000001225 therapeutic effect Effects 0.000 title description 2
- 150000003862 amino acid derivatives Chemical class 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 claims abstract description 23
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 20
- 235000015493 Chenopodium quinoa Nutrition 0.000 claims abstract description 20
- 125000004442 acylamino group Chemical group 0.000 claims abstract description 17
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 230000010933 acylation Effects 0.000 claims abstract description 8
- 238000005917 acylation reaction Methods 0.000 claims abstract description 8
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims abstract description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004472 Lysine Substances 0.000 claims abstract description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 5
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 5
- -1 undecylenoyl Chemical group 0.000 claims abstract description 5
- 150000001412 amines Chemical class 0.000 claims abstract description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001231 choline Drugs 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims abstract description 4
- 239000002184 metal Substances 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- 235000010755 mineral Nutrition 0.000 claims abstract description 4
- 150000007530 organic bases Chemical class 0.000 claims abstract description 4
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 3
- 230000001166 anti-perspirative effect Effects 0.000 claims abstract description 3
- 239000003213 antiperspirant Substances 0.000 claims abstract description 3
- 239000003599 detergent Substances 0.000 claims abstract description 3
- 230000004936 stimulating effect Effects 0.000 claims abstract description 3
- 239000012871 anti-fungal composition Substances 0.000 claims abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000011573 trace mineral Substances 0.000 claims description 4
- 235000013619 trace mineral Nutrition 0.000 claims description 4
- 150000002739 metals Chemical class 0.000 claims description 3
- 241000871189 Chenopodiaceae Species 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract description 2
- 150000001342 alkaline earth metals Chemical class 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 229940072033 potash Drugs 0.000 abstract description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract description 2
- 235000015320 potassium carbonate Nutrition 0.000 abstract description 2
- 235000013311 vegetables Nutrition 0.000 abstract description 2
- 239000004411 aluminium Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000007065 protein hydrolysis Effects 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- CNDHHGUSRIZDSL-UHFFFAOYSA-N 1-chlorooctane Chemical compound CCCCCCCCCl CNDHHGUSRIZDSL-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- BFVRFWIQTACAPT-KRWDZBQOSA-N N-Palmitoyl serine Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(O)=O BFVRFWIQTACAPT-KRWDZBQOSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 210000004896 polypeptide structure Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Cosmetics (AREA)
Abstract
Description
- 1- 1
NOUVEAUX ACYLAMINOACIDESNEW ACYLAMINOACIDS
L'acylation d'une chaîne grasse sur des acides aminés ou sur des peptides à chaîne courte ou moyenne,obtenus par hydrolyse de protéines animales ou végétales a fait l'objet de nombreux brevets portant tant sur leur préparation que leur destination d'emploi, et en particulier dans les domaines cosmétiques,pharmaceutiques The acylation of a fatty chain on amino acids or on short or medium chain peptides obtained by hydrolysis of animal or vegetable proteins has been the subject of numerous patents relating both to their preparation and to their destination of use, and in particular in the cosmetic, pharmaceutical fields
et de l'agriculture.and agriculture.
L'étude de la technique d'acylation peut être illustrée par les publications Chemical Abstract Volume 101,1984,59982d et Volume 102, The study of the acylation technique can be illustrated by the publications Chemical Abstract Volume 101,1984,59982d and Volume 102,
1985,115009b,ainsi que par de nombreux brevets. 1985, 115009b, as well as by numerous patents.
La présente invention a pour objet de réaliser de nouvelles structures acylaminoacides faiblement odorantes et peu colorées obtenues à partir d'hydrolysats partiel ou total des protéines The object of the present invention is to produce new weakly odorous and poorly colored acylamino acid structures obtained from partial or total hydrolysates of proteins.
contenues dans les graines de CHENOPODIUM QUINOA (CHENOPODIACEAE). contained in the seeds of CHENOPODIUM QUINOA (CHENOPODIACEAE).
L'hydrolyse totale de ces structures polypeptidiques mène à la libération des acides aminés qui les composent,avec deux acides aminés particulièrement dominants,l'acide glutamique dont la teneur moyenne se situe entre 20 et 25 % et l'acide aspartique qui The total hydrolysis of these polypeptide structures leads to the release of the amino acids which compose them, with two particularly dominant amino acids, glutamic acid whose average content is between 20 and 25% and aspartic acid which
représente entre 12 et 15%.represents between 12 and 15%.
Les 7 acides aminés cités ci-après représentent au total environ 50% The 7 amino acids listed below represent approximately 50% in total
des chaînes polypeptidiques.polypeptide chains.
Ce sont: la glycine entre 8 et 10 %, l'arginine et la lysine entre 6 et 8 % chacun, l'alanine,la sérine et la leucine entre 5 et 7 % chacun, These are: glycine between 8 and 10%, arginine and lysine between 6 and 8% each, alanine, serine and leucine between 5 and 7% each,
la proline entre 4 et 6 %.proline between 4 and 6%.
Les 7 acides aminés cités ci-après représentent au total entre 15 The 7 amino acids listed below represent a total of between 15
et 20 % des chaînes polypeptidiques. and 20% of the polypeptide chains.
Ce sont: la thréonine entre 3,8 et 4,5 %, la valine entre 3 et 4 %, l'histidine et l'isoleucine entre 2 et 3 % chacun, These are: threonine between 3.8 and 4.5%, valine between 3 and 4%, histidine and isoleucine between 2 and 3% each,
l'isoleucine entre 2 et 3 %.isoleucine between 2 and 3%.
la méthionine entre 1,8 et 2,5 % la phénylalanine entre 1 et 1,5 % la tyrosine entre 0,6 et 1 % De par la méthode d'hydrolyse utilisée,on a pu noter l'absence ou des methionine between 1.8 and 2.5% phenylalanine between 1 and 1.5% tyrosine between 0.6 and 1% From the hydrolysis method used, we could note the absence or
traces de cystine et de tryptophane. traces of cystine and tryptophan.
Il est intéressant de constater que la composition de l'hydrolysat total de protéines de graines de CHENOPODIUM QUINOA est voisine de It is interesting to note that the composition of the total seed protein hydrolyzate of CHENOPODIUM QUINOA is close to
celle de l'hydrolysat total de protéines de soja (GLYCINE MAX). that of the total soy protein hydrolyzate (GLYCINE MAX).
Le faible volume occupé par les graines de CHENOPODIUM QUINOA permet The small volume occupied by CHENOPODIUM QUINOA seeds allows
d'effectuer l'hydrolyse partielle ou totale directement. to carry out partial or total hydrolysis directly.
Pour cela trois parties (en poids) de graines sont plongées dans une solution contenant trois parties d'acide chlorhydrique à 33 % et une For this, three parts (by weight) of seeds are immersed in a solution containing three parts of 33% hydrochloric acid and one
partie d'eau.part of water.
L'ensemble est chauffé à une température suffisante pour obtenir un reflux,jusqu'à l'obtention d'une solution ayant une réaction The whole is heated to a temperature sufficient to obtain reflux, until a solution having a reaction is obtained.
biurétique négative (5 heures de chauffage à reflux environ). negative biuretic (approximately 5 hours of reflux heating).
-2- L'hydrolysat obtenu est neutralisé par une solution de soude à 30 % jusqu'à pH 5 environ,puis traité par un charbon actif pour la décoloration. Afin de pouvoir déterminer la quantité de chlorure ou d'anhydride d'acides gras ou organiques nécessaires à l'acylation,on effectue le -2- The hydrolyzate obtained is neutralized with a 30% sodium hydroxide solution up to approximately pH 5, then treated with an activated carbon for discoloration. In order to be able to determine the quantity of chloride or anhydride of fatty or organic acids necessary for the acylation, the
titrage de l'hydrolysat par formol titration. titration of the hydrolyzate by formalin titration.
Pour les cas d'utilisation de chaînes grasses à partir de 5 carbones, on effectue l'acylation en versant l'agent acylant dans l'hydrolysat, à des températures comprises entre 15 et 50 C,selon la nature de In the case of the use of fatty chains from 5 carbons, the acylation is carried out by pouring the acylating agent into the hydrolyzate, at temperatures between 15 and 50 ° C., depending on the nature of
l'agent acylant,et en maintenant le pH du milieu entre 10 et 11. the acylating agent, and maintaining the pH of the medium between 10 and 11.
Lorsque tout le réactif d'acylation est introduit,on porte la température du milieu réactionnel à 70 C pendant une heure dans le cas d'utilisation de chlorures d'acides gras.On refroidit ensuite le milieu pour arriver & une température inférieure à 30 C,puis on traite à l'acide chlorhydrique à 33 % pour arriver à un pH voisin de 1.11 se forme alors une matte blanche,volumineuse,comportant When all of the acylation reagent is introduced, the temperature of the reaction medium is brought to 70 ° C. for one hour in the case of the use of fatty acid chlorides. The medium is then cooled to reach a temperature below 30 ° C. , then treated with hydrochloric acid at 33% to arrive at a pH close to 1.11 then forms a white, voluminous matte, comprising
environ 70 % d'eau.about 70% water.
Lavée sur filtre pour éliminer l'acide chlorhydrique,cette matte sera déshydratée sous vide,à une température inférieure à 50 C pour éviter Washed on filter to remove hydrochloric acid, this matte will be dehydrated under vacuum, at a temperature below 50 C to avoid
l'apparition d'une coloration.the appearance of a coloration.
On obtient des acylaminoacides liposolubles,qui selon la nature de la chaîne grasse utilisée,seront pâteux ou pourront être réduits en poudre. Lorsque la chaîne acyle utilisée comporte de 1 à 4 atomes de carbone (acétyle,propionyl,butyryl),et après avoir amené le pH du milieu vers 1 1,5 puis éliminé l'acide chlorhydrique issu de la réaction et l'eau par distillation sous vide,l'acylaminoacide hydrosoluble obtenu peut être extrait par un solvant approprié comme l'éthanol par Liposoluble acylamino acids are obtained, which, depending on the nature of the fatty chain used, will be pasty or may be reduced to powder. When the acyl chain used contains from 1 to 4 carbon atoms (acetyl, propionyl, butyryl), and after having brought the pH of the medium to 1 1.5 then eliminated the hydrochloric acid resulting from the reaction and the water by distillation under vacuum, the water-soluble acylamino acid obtained can be extracted with an appropriate solvent such as ethanol by
exemple.example.
Les acylaminoacides réalisés selon l'invention,sont des mélanges d'aminoacides acylés ayant la structure suivante: The acylamino acids produced according to the invention are mixtures of acylated amino acids having the following structure:
R1-NH-CO-R2R1-NH-CO-R2
dans lesquelles R1 représente la structure de l'acide aminé o la fonction amine est fixée, et R2 représente un radical d'acides gras in which R1 represents the structure of the amino acid where the amine function is fixed, and R2 represents a radical of fatty acids
de C5 à C30 ou d'un acide organique de Cl à C4. from C5 to C30 or an organic acid from Cl to C4.
On obtient ainsi un mélange d'acylaminoacides,aisément révélables en chromatographie sur couche mince,et correspondant précisement à la A mixture of acylamino acids is thus obtained, easily revealed by thin layer chromatography, and corresponding precisely to the
composition de l'hydrolysat de graines de CHENOPODIUM QUINOA. composition of CHENOPODIUM QUINOA seed hydrolyzate.
EXEMPLES DE PREPARATION D'ACYLAMINOACIDES SELON L'INVENTION: EXAMPLES OF PREPARATION OF ACYLAMINOACIDS ACCORDING TO THE INVENTION:
EXEMPLE No 1 - Hvdrolvse des araines de CHENOPODIUM OUINOA: Dans un réacteur contenant 300 ml d'acide chlorhydrique à 33 % et EXAMPLE No. 1 - Hvdrolvse of the spores of CHENOPODIUM OUINOA: In a reactor containing 300 ml of 33% hydrochloric acid and
ml d'eau,on introduit 300 g de graines de CHENOPODIUM QUINOA. ml of water, 300 g of seeds of CHENOPODIUM QUINOA are introduced.
On porte la température jusqu'à l'ébullition (vers 100 C) pendant The temperature is brought to the boil (around 100 C) for
environ 5 heures.about 5 hours.
Après refroidissement,on amène à l'aide d'une solution de soude l'hydrolysat obtenu à pH 5,et on filtre pour éliminer les éléments hydrocarbonés restants des graines.Avec du charbon actif,on effectue la décoloration de l'hydrolysat,soit à température ambiante,soit à -3- After cooling, the hydrolyzate obtained is obtained with a sodium hydroxide solution at pH 5, and filtered to remove the remaining hydrocarbon elements from the seeds. With activated carbon, the hydrolyzate is decoloured, ie at room temperature, i.e. -3-
chaud vers 80 C.hot around 80 C.
On détermine le titre de l'hydrolysat par formol titration ce qui permet de calculer la quantité d'agent acylant à utiliser par rapport au contenu de fonctions NH2 des acides aminés libérés par l'hydrolyse. FXEMPLE No 2 - Acvlation Dar le chlorure de Dalmitovl: A température ambiante,à 200 ml d'hydrolysat obtenu selon l'exemple 1 on ajoute sous agitation 400 ml d'eau et de la soude,pour porter le pH vers 10,5.On fait couler goutte à goutte le chlorure de palmitoyl en maintenant le pH entre 10,5 et 11 avec de la soude.La température du milieu monte vers 40 C.Lorsque tout le chlorure de palmitoyl a été The titer of the hydrolyzate is determined by formalin titration, which makes it possible to calculate the quantity of acylating agent to be used relative to the content of NH 2 functions of the amino acids released by the hydrolysis. FXAMPLE No 2 - Acquisition of Dalmitovl chloride: At room temperature, to 200 ml of hydrolyzate obtained according to Example 1 is added with stirring 400 ml of water and soda, to bring the pH to 10.5. The palmitoyl chloride is poured in dropwise while maintaining the pH between 10.5 and 11 with sodium hydroxide. The temperature of the medium rises to 40 C. When all of the palmitoyl chloride has been
introduit,on porte la température du milieu à 70 C pendant une heure. introduced, the temperature of the medium is brought to 70 ° C. for one hour.
Après refroidissement,on ajoute une solution d'acide chlorhydrique pour arriver à pH l.Le mélange d'acylaminoacides décante sous la After cooling, a hydrochloric acid solution is added to reach pH 1. The mixture of acylamino acids decanted under the
forme d'une matte blanchâtre qu'on lavera à l'eau froide. form of a whitish matte which will be washed in cold water.
Déshydratée sous vide à une température inférieure à 50 C pour éviter Dehydrated under vacuum at a temperature below 50 C to avoid
des colorations,on obtient un produit fondant vers 60 - 65 C. colorings, a melting product is obtained around 60 - 65 C.
EXEMPLE N 3 - Acvlation par le chlorure de caprvlovl: Dans les mêmes conditions que dans l'exemple 2,à 200 ml d'hydrolysat obtenu suivant l'exemple 1,on ajoute selon le même mode opératoire le chlorure de capryloyl.Après acylation et chauffage à 70 C pendant une heure,on refroidit le milieu et on libère avec de l'acide chlorhydrique le dérivé obtenu.Le produit obtenu est liquide et de EXAMPLE N 3 - Acvlation with caprvlovl chloride: Under the same conditions as in Example 2, to 200 ml of hydrolyzate obtained according to Example 1, capryloyl chloride is added according to the same procedure. After acylation and heating at 70 ° C. for one hour, the medium is cooled and the derivative obtained is released with hydrochloric acid. The product obtained is liquid and
couleur brun rougeâtre.reddish brown color.
Après décantations et lavages successifs avec de l'eau pour éliminer After decantation and successive washing with water to remove
l'acide chlorhydrique restant,on le déshydrate sous vide. the hydrochloric acid remaining, it is dried under vacuum.
L'invention concerne également des compositions diverses préparées avec les acylaminoacides de l'invention,lesquelles pouvant être utilisées dans les domaines cosmétique,hygiénique,thérapeutique et en The invention also relates to various compositions prepared with the acylamino acids of the invention, which can be used in the cosmetic, hygienic, therapeutic and
agriculture.Agriculture.
Ces nouveaux acylaminoacides peuvent être utilisés tels quels,c'est à dire sous leur forme acylée,ou sous la forme de leurs sels respectifs avec des alcalino-métaux ou des bases organiques,tels que les différentes amines,l'ammoniaque ou les alcools aminés,ou des bases These new acylamino acids can be used as such, that is to say in their acylated form, or in the form of their respective salts with alkaline metals or organic bases, such as the various amines, ammonia or amino alcohols , or bases
biologiques comme la choline,la lysine. organic like choline, lysine.
Les métaux alcalino-terreux peuvent également être utilisés,tout comme les métaux comme le fer,le manganèse,le cobalt,le cuivre,et en Alkaline earth metals can also be used, just like metals like iron, manganese, cobalt, copper, and
général les oligoéléments.general trace elements.
Du choix de l'agent utilisé pour la formation de sels dépendra The choice of agent used for salt formation will depend
l'usage auquel le composé obtenu est destiné. the use for which the compound obtained is intended.
Par exemple,pour la réalisation de compositions antimicrobiennes, antifongiques et antivirales,on utilisera des agents acylants en C8 For example, for the production of antimicrobial, antifungal and antiviral compositions, acylating agents at C8 will be used
ou Cll.or Cll.
Pour la réalisation de compositions détergentes,on préférera la salification par une base minérale,organique ou biologique de lacylaminoacide dont la fraction acyle correspond à la chaîne laurique. Le produit obtenu ainsi est principalement destiné à - 4 - l'hygiène corporelle et se caractérise,à la teneur de 20 %,par un pouvoir moussant et une douceur exceptionnelle caractéristique.Comme base minérale,on pourra utiliser la soude ou la potasse,comme base organique la monoéthanolamine ou la triéthanolamine,et comme base biologique la choline,la lysine ou l'ammoniaque. Des compositions antisudorales actives sur l'hyperhydrose pourront être réalisées avec des sels d'aluminium mono et dibasiques et des For the production of detergent compositions, salification with a mineral, organic or biological base of lacylamino acid, the acyl fraction of which corresponds to the lauric chain, is preferred. The product thus obtained is mainly intended for personal hygiene and is characterized, at the content of 20%, by a foaming power and an exceptional characteristic softness. As a mineral base, it is possible to use soda or potash, as organic base monoethanolamine or triethanolamine, and as a biological base choline, lysine or ammonia. Antiperspirant compositions active on hyperhydrosis can be produced with mono and dibasic aluminum salts and
agents acylants en C8 ou Cll.acylating agents in C8 or Cll.
La présence de sérine en quantité assez importante (5 à 7 %) donne aux acylaminoacides ainsi réalisés des caractéristiques antidéshydratantes et antitoxiques particulièrement intéressantes dans le domaine cosmétique,en particulier lorsque la fraction acyle utilisée est la chaîne palmitoyl (A. KAPLAN:"Hydrogene bonding properties of N- Palmitoyl_Serine" - Journal of Colloid and interface The presence of serine in a fairly large amount (5 to 7%) gives the acylamino acids thus produced anti-dehydrating and anti-toxic characteristics which are particularly advantageous in the cosmetic field, in particular when the acyl fraction used is the palmitoyl chain (A. KAPLAN: "Hydrogene bonding properties of N- Palmitoyl_Serine "- Journal of Colloid and interface
1s Science,1967 (25),63-70); MAC FARLANE:Adv Lipid Res. 1964(2),96- 1s Science, 1967 (25), 63-70); MAC FARLANE: Adv Lipid Res. 1964 (2), 96-
). Dans le domaine de l'hygiène,on pourra greffer des chaînes acyles comportant de 3 à 11 atomes de carbone,et les formes salifiées seront utilisables. En agriculture, les acylaminoacides en C8 & C22, salifiés par des oligoéléments (dont le cuivre en particulier),pourront être utilisés comme agents de protection ou de stimulation de la croissance des végétaux. En pharmacie,des compositions antiinflammatoires en C8 à C22 pourront être réalisées pour lutter contre les inflammations microbiennes, ). In the field of hygiene, it will be possible to graft acyl chains comprising from 3 to 11 carbon atoms, and the salified forms will be usable. In agriculture, the C8 & C22 acylamino acids, salified with trace elements (including copper in particular), can be used as agents for protecting or stimulating plant growth. In pharmacies, anti-inflammatory compositions in C8 to C22 can be produced to fight against microbial inflammations,
fongiques ou virales de la peau.fungal or viral skin.
Diverses compositions réalisées selon l'invention peuvent être citées à titre d'exemples non limitatifs: 1 ) - Produit cosmétiqcue du tvDe shampooina: Lauroyl Chenopodium Quinoa aminoacides (20% M.A.).. . 25,0 Octanoyl Chenopodium Quinoa aminoacides............. 0,5 Chlorure de sodium.................................. 4,0 Eau déminéralisée................................... qs 100 2o)- Produit cosmétique du tvDe crème: DEA-cétylphosphate................... Various compositions produced according to the invention can be cited by way of nonlimiting examples: 1) - Cosmetic product of shampoo TV: Lauroyl Chenopodium Quinoa amino acids (20% M.A.). 25.0 Octanoyl Chenopodium Quinoa amino acids ............. 0.5 Sodium chloride ........................ .......... 4.0 Demineralized water ................................... qs 100 2o) - Cosmetic product of cream tv: DEA-cetylphosphate ...................
............. 3,5 Acide stéarique...................................DTD: .. 1,5 Palmitate d'isopropyle.............................. 5,0 Alcool cétylique.................................... 1,0 Palmitoyl Chenopodium Quinoa aminoacides............ 5,0 Glycérine......DTD: ..................................... 7,0 Octanoyl Chenopodium Quinoa aminoacides............. 0,5 Lanoline........................... DTD: ................. 3,5 Gel d'acides carboxyvinyliques.................. DTD: .... 4,0 Eau déminéralisée................................... qs 100 3 ) - Savon Dour la toilette: Base savon sur coprah................ DTD: .............. 94,0 Lauroyl Chenopodium Quinoa aminoacides......... 4,0 Palmitoyl Chenopodium Quinoa aminoacides........ 1,0 Octanoyl Chenopodium Quinoa aminoacides............. 1,0 4 ) - Composition antisentiaue contre l'acné: Octanoyl Chenopodium Quinoa aminoacides....... .DTD: ..... 5,0 Huile de ricin polyéthoxylée........................ 25, 0 Eau déminéralisée................................... qs 100 ) - Composition Dour lutter contre l'hvDerhvdrose: Octanoyl Chenopodium Quinoa aminoacides............. 3,0 Palmitoyl Chenopodium Quinoa aminoacides............ 1,0 Ethanol & 35 % v/v......................DTD: ............ 96,0 6 ) - Composition antiDersoirante: Undécylenoyl Chenopodium Quinoa aminoacides......... 5,0 (salifié par l'aluminium forme dibasique) Glycérol palmitostéarate............................ 7,0 Stéarate de polyoxyéthylèneglycol................... 4,0 Propylèneglycol..................................... 12,0 Eau déminéralisée................................... qs 100 7 ) - Produit rotecteur des véaétaux: Octanoyl Chenopodium Quinoa aminoacides......... 3,0 (salifié par du cuivre) Palmitoyl Chenopodium Quinoa aminoacides........ 1,0 Solution d'ammoniaque & 30 %..................... DTD: ... 6,0 Eau déminéralisée................................... qs 100 6 -..DTD: ............. 3.5 Stearic acid ................................ ... DTD: .. 1.5 Isopropyl palmitate .............................. 5.0 Cetyl alcohol. ................................... 1.0 Palmitoyl Chenopodium Quinoa amino acids ........ .... 5.0 Glycerin ...... DTD: .................................. ... 7.0 Octanoyl Chenopodium Quinoa amino acids ............. 0.5 Lanolin ....................... .... DTD: ................. 3.5 Gel of carboxyvinyl acids .................. DTD : .... 4.0 Demineralized water ................................... qs 100 3) - Soap for the toilet: soap base on copra ................ DTD: .............. 94.0 Lauroyl Chenopodium Quinoa amino acids .. ....... 4.0 Palmitoyl Chenopodium Quinoa amino acids ........ 1.0 Octanoyl Chenopodium Quinoa amino acids ............. 1.0 4) - Antisentiaue composition against acne: Octanoyl Chenopodium Quinoa amino acids ....... .DTD: ..... 5.0 Polyethoxylated castor oil ................... ..... 25, 0 Cleared water made ................................... qs 100) - Composition Dour fight against hvDerhvdrose: Octanoyl Chenopodium Quinoa amino acids ............. 3.0 Palmitoyl Chenopodium Quinoa amino acids ............ 1.0 Ethanol & 35% v / v ...... ................ DTD: ............ 96.0 6) - AntiDissoirante composition: Undécylenoyl Chenopodium Quinoa amino acids ....... .. 5.0 (salified with aluminum dibasic form) Glycerol palmitostearate ............................ 7.0 Polyoxyethylene glycol stearate ................... 4.0 Propylene glycol ........................... .......... 12.0 Demineralized water ................................... qs 100 7) - Vegetable rotator: Octanoyl Chenopodium Quinoa amino acids ......... 3.0 (salified with copper) Palmitoyl Chenopodium Quinoa amino acids ........ 1.0 Solution of ammonia & 30% ..................... DTD: ... 6.0 Demineralized water ............... .................... qs 100 6 - .. DTD:
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9703135A FR2760746B3 (en) | 1997-03-14 | 1997-03-14 | NEW ACYLAMINOACIDS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9703135A FR2760746B3 (en) | 1997-03-14 | 1997-03-14 | NEW ACYLAMINOACIDS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2760746A1 true FR2760746A1 (en) | 1998-09-18 |
FR2760746B3 FR2760746B3 (en) | 1999-05-21 |
Family
ID=9504809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9703135A Expired - Fee Related FR2760746B3 (en) | 1997-03-14 | 1997-03-14 | NEW ACYLAMINOACIDS |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2760746B3 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1221313A2 (en) * | 2001-01-09 | 2002-07-10 | Zschimmer & Schwarz Italiana S.p.A. | Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions |
WO2002057217A2 (en) * | 2001-01-18 | 2002-07-25 | Cognis Deutschland Gmbh & Co. Kg | Method for producing acyl amino acids |
WO2002062304A2 (en) * | 2001-01-18 | 2002-08-15 | Cognis Deutschland Gmbh & Co.Kg | Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate |
WO2003039496A1 (en) * | 2001-11-07 | 2003-05-15 | Zschimmer & Schwarz Italiana S.P.A. | Detergent and cosmetic compositions comprising capryloyl glutamate salts and/or capryloyl hydrolysate salts of wheat and/or rice protein |
WO2003068184A1 (en) * | 2002-02-14 | 2003-08-21 | Cognis Deutschland Gmbh & Co. Kg | Use of low molecular protein hydrolysates as anti-inflammable active substances |
US20100136144A1 (en) * | 2006-12-28 | 2010-06-03 | Laboratoires Expanscience | Composition containing a quinoa extract for dermatological use |
-
1997
- 1997-03-14 FR FR9703135A patent/FR2760746B3/en not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1221313A2 (en) * | 2001-01-09 | 2002-07-10 | Zschimmer & Schwarz Italiana S.p.A. | Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions |
EP1221313A3 (en) * | 2001-01-09 | 2003-11-26 | Zschimmer & Schwarz Italiana S.p.A. | Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions |
WO2002057217A2 (en) * | 2001-01-18 | 2002-07-25 | Cognis Deutschland Gmbh & Co. Kg | Method for producing acyl amino acids |
WO2002062304A2 (en) * | 2001-01-18 | 2002-08-15 | Cognis Deutschland Gmbh & Co.Kg | Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate |
WO2002062304A3 (en) * | 2001-01-18 | 2003-02-27 | Cognis Deutschland Gmbh | Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate |
WO2002057217A3 (en) * | 2001-01-18 | 2004-03-25 | Cognis Deutschland Gmbh | Method for producing acyl amino acids |
US6828452B2 (en) | 2001-01-18 | 2004-12-07 | Cognis Deutschland Gmbh & Co. Kg | Method for producing acyl amino acids |
WO2003039496A1 (en) * | 2001-11-07 | 2003-05-15 | Zschimmer & Schwarz Italiana S.P.A. | Detergent and cosmetic compositions comprising capryloyl glutamate salts and/or capryloyl hydrolysate salts of wheat and/or rice protein |
WO2003068184A1 (en) * | 2002-02-14 | 2003-08-21 | Cognis Deutschland Gmbh & Co. Kg | Use of low molecular protein hydrolysates as anti-inflammable active substances |
US20100136144A1 (en) * | 2006-12-28 | 2010-06-03 | Laboratoires Expanscience | Composition containing a quinoa extract for dermatological use |
US9125879B2 (en) * | 2006-12-28 | 2015-09-08 | Laboratoires Expanscience | Composition containing a quinoa extract for dermatological use |
Also Published As
Publication number | Publication date |
---|---|
FR2760746B3 (en) | 1999-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0586501B1 (en) | N-acyl derivatives of amino acid mixtures derived from cereal protein hydrolysates and applications thereof | |
FR2835528A1 (en) | NEW PEPTIDIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC AND COSMETIC APPLICATION | |
FR2705673A1 (en) | Compositions comprising amino acid derivatives, methods for their preparation and uses thereof | |
CA2569685A1 (en) | Indolecarboxylic compounds and their use as pharmaceutical compounds | |
FR2781231A1 (en) | New parathyroid hormone fragment peptides, used as lipolysis stimulants in topically applied cosmetic compositions for slimming treatment of excessive weight in hips and thighs | |
EP0593506B1 (en) | Lipoaminoacids, preparation method and applications | |
EP0601911B1 (en) | Acylamino acids obtained by acylation of protein hydrolipates and antimicrobial, antiparasitic or cosmetic compositions containing them | |
FR2503151A1 (en) | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use | |
FR2900656A1 (en) | GEM-DIFLUORINE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE, IN PARTICULAR FOR THE PRESERVATION OF BIOLOGICAL MATERIALS | |
FR2546164A1 (en) | NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ELASTASE INHIBITORS | |
FR2582306A1 (en) | N-ACYL-THIAZOLIDINE-4-CARBOXYLIC ACID SALTS AND 6-PIPERIDINO-2,4-DIAMINOPYRIMIDINE-3-OXIDE AND COSMETIC-DERMATOLOGICAL COMPOSITIONS CONTAINING SAME | |
EP0457701A1 (en) | Derivatives of endogenous mediators, their salts, process for preparation, application and compositions containing them | |
FR2760746A1 (en) | New acyl:amino acid derivatives used in cosmetics, hygiene compositions, agriculture and therapeutic compositions | |
FR2702766A1 (en) | New synthetic compounds, process for preparing them and use in cosmetic and dermopharmaceutical preparations for improving suntanning (bronzing) | |
FR2673103A1 (en) | ASSOCIATION OF DIHYDROXYACETONE AND DISUBSTITUTED INDOLIC DERIVATIVES FOR CONFINING TO THE SKIN A NATURAL TANNING SIMILAR COLOR, PROCESS AND COLORING AGENTS. | |
FR2503144A1 (en) | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use | |
WO1987004923A2 (en) | Aromatic amides absorbing the u.v. | |
FR2766366A1 (en) | USE OF AT LEAST ONE LIPOAMINOACID AS AN ANTAGONIST OF THE SUBSTANCE P IN A COSMETIC FORMULATION FOR SOOTHING AND / OR PROTECTING ALL SKIN TYPES AND, IN PARTICULAR, SENSITIVE SKIN | |
CA2273989C (en) | New histidine derivatives, preparation process, and their use as free antiradical agents | |
EP0099286B1 (en) | Compound containing a tripeptide sequence of the threonyl-lysyl proline-type, or similar, useful as an anti-inflammatory, anti-allergic or antalgesic agent | |
JPH1180105A (en) | N-acyl amino acids and cosmetics using the same | |
FR2763842A1 (en) | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING THREONINE OR SERINE DERIVATIVES | |
WO2006035142A1 (en) | Preparation of phenol-amide compounds with antioxidant properties | |
CA2300603C (en) | New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses | |
JP3736405B2 (en) | Amino acid derivatives and antioxidants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |